Skip to main content
Premium Trial:

Request an Annual Quote

Cheryl Moore

The New York Genome Center (NYGC) has appointed Cheryl Moore as president and COO. She will assume the position in January. Moore will be responsible for all business functions of NYGC, reporting to and partnering with Robert Darnell to set overall strategic direction and make key business decisions for the organizations.

Moore comes to NYGC after five years as the executive vice president and COO of the Howard Hughes Medical Institute, where she has led collaborative strategic efforts and oversees key operational functions. From 2004 to 2010, she served as COO of HHMI's Janelia Research Campus, where she was responsible for all operational aspects of the campus and its $100 million budget. Prior to HHMI, Moore served as senior vice president and COO of the Sanford Burnham Prebys Medical Discovery Institute.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.